| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |